Komori
Linical (2183) · FactFirst stated

Completion of Purchase Price Allocation for the Accelovance Acquisition

First written in FY2020-Q1. . Latest entry: FY2020-Q1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Finalization of Provisional Accounting Treatment for Business CombinationsA theme 160 companies write about · 6 as a headwind · 2 as a tailwind

46 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 157 companies compared. The sentences above are computed from all 157.Comparing 200 of the theme's 203 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2020-Q1First statedAnnual report

    「For the business combination with Accelovance, Inc. (now Linical Accelovance America, Inc.) completed on 16 April 2018, provisional accounting treatment had been applied during the first quarter of the previous consolidated fiscal year, but the purchase price allocation to assets and liabilities was completed by the end of the previous consolidated fiscal year.」

    Purchase price allocation for the acquisition of LAA was completed, and the revisions were reflected in the comparative information. Contract backlog-related assets of ¥16,082 thousand and customer-related assets of ¥92,740 thousand, among others, were recognized, and goodwill was revised from ¥3,356,005 thousand to ¥3,418,379 thousand.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Linical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Completion of Purchase Price Allocation for the Accelovance Acquisition | Linical Co.,Ltd. (2183) | Komori